Get the Stockscreener App
66.26
4.56%
2.89
Apogee Therapeutics Inc stock is traded at $66.26, with a volume of 625.47K.
It is up +4.56% in the last 24 hours and up +18.60% over the past month.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
See More
Previous Close:
$63.37
Open:
$63.23
24h Volume:
625.47K
Relative Volume:
0.89
Market Cap:
$4.53B
Revenue:
-
Net Income/Loss:
$-146.66M
P/E Ratio:
-24.06
EPS:
-2.7541
Net Cash Flow:
$-133.21M
1W Performance:
+1.16%
1M Performance:
+18.60%
6M Performance:
+64.91%
1Y Performance:
+54.60%
1-Day Range:
$62.89
$66.88
1-Week Range:
$61.81
$67.66
52-Week Range:
$26.20
$67.66
Apogee Therapeutics Inc Stock (APGE) Company Profile
Name
Apogee Therapeutics Inc
Sector
Industry
Phone
650-394-5230
Address
221 CRESCENT ST., WALTHAM
Compare APGE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APGE
Apogee Therapeutics Inc
|
66.26 | 4.33B | 0 | -146.66M | -133.21M | -2.7541 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-25 | Initiated | Craig Hallum | Buy |
| Oct-21-25 | Initiated | Mizuho | Outperform |
| Sep-25-25 | Initiated | RBC Capital Mkts | Outperform |
| Jul-07-25 | Reiterated | BTIG Research | Buy |
| Mar-13-25 | Initiated | Citigroup | Buy |
| Nov-25-24 | Initiated | Canaccord Genuity | Buy |
| May-10-24 | Initiated | BofA Securities | Buy |
| Dec-20-23 | Initiated | BTIG Research | Buy |
| Aug-08-23 | Initiated | Guggenheim | Buy |
| Aug-08-23 | Initiated | Jefferies | Buy |
| Aug-08-23 | Initiated | Stifel | Buy |
| Aug-08-23 | Initiated | TD Cowen | Outperform |
| Aug-08-23 | Initiated | Wedbush | Outperform |
View All
Apogee Therapeutics Inc Stock (APGE) Latest News
Is Apogee Therapeutics Inc a good long term investmentInsider Trading Compliance & High Yield Trading Alerts - earlytimes.in
Responsive Playbooks and the APGE Inflection - news.stocktradersdaily.com
Apogee Therapeutics stock hits 52-week high at $67.66 By Investing.com - Investing.com Nigeria
Is Apogee Therapeutics Inc. stock recession proofWeekly Stock Summary & High Conviction Buy Zone Picks - newser.com
How to track smart money flows in Apogee Therapeutics Inc.2025 Price Momentum & Daily Market Momentum Tracking - newser.com
How to use Fibonacci retracement on Apogee Therapeutics Inc.Market Activity Recap & Risk Controlled Stock Pick Alerts - newser.com
How to integrate Apogee Therapeutics Inc. into portfolio analysis toolsPortfolio Value Report & Expert Approved Momentum Ideas - newser.com
Published on: 2025-11-15 19:11:00 - newser.com
Assessing Apogee Therapeutics (APGE) Valuation After Recent Surge in Investor Interest - Yahoo Finance
Why Apogee Therapeutics (APGE) Is Up 19.7% After Strong APG333 Trial Data and Cash Infusion - Yahoo Finance
Can volume confirm reversal in Apogee Therapeutics Inc.2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
Insider Sell Alert: Jane Henderson Sells 2,000 Shares of Apogee Therapeutics Inc (APGE) - GuruFocus
Henderson Jane, CFO of Apogee Therapeutics, sells $130k in stock - Investing.com Canada
Henderson Jane, CFO of Apogee Therapeutics, sells $130k in stock By Investing.com - Investing.com South Africa
[Form 4] Apogee Therapeutics, Inc. Insider Trading Activity - Stock Titan
Apogee Therapeutics CFO Sells 2,000 Shares - TradingView
CFO Henderson Sells 2,000 ($130K) Of Apogee Therapeutics Inc [APGE] - TradingView
Is Apogee Therapeutics Inc. (APGE) Outperforming Other Medical Stocks This Year? - MSN
APGE | Apogee Therapeutics Inc. SEC Filings - MarketWatch
Is Apogee Therapeutics Inc. stock positioned for digital transformation2025 Macro Impact & Daily Stock Momentum Reports - newser.com
Will Apogee Therapeutics Inc. stock remain a Wall Street favoriteWeekly Earnings Recap & Safe Capital Growth Tips - Fundação Cultural do Pará
Apogee Therapeutics’ APG777 Study: A Potential Breakthrough in Atopic Dermatitis Treatment - MSN
Real time scanner hits for Apogee Therapeutics Inc. explainedJuly 2025 Gainers & Low Drawdown Momentum Trade Ideas - newser.com
Apogee Therapeutics Insider Sold Shares Worth $1,260,236, According to a Recent SEC Filing - MarketScreener
Apogee Therapeutics CEO Henderson sells $1.26 million in stock By Investing.com - Investing.com Nigeria
Published on: 2025-11-13 23:54:39 - newser.com
CEO Michael Henderson Sells 20,000 Shares of Apogee Therapeutics Inc (APGE) - GuruFocus
Henderson, Apogee Therapeutics CFO, sells $60k in stock By Investing.com - Investing.com Canada
Apogee Therapeutics CEO Henderson sells $1.26 million in stock - Investing.com India
Apogee Therapeutics Executives Sell Shares - TradingView
CFO Henderson Sells 1,000 ($60K) Of Apogee Therapeutics Inc [APGE] - TradingView
CEO Henderson Sells 20,000 ($1.3M) Of Apogee Therapeutics Inc [APGE] - TradingView
CEO Henderson Files To Sell 100,000 Of Apogee Therapeutics Inc [APGE] - TradingView
Apogee Therapeutics Reports Q3 2025 Financial Progress - MSN
Published on: 2025-11-12 14:24:11 - newser.com
Apogee Therapeutics stock hits 52-week high at 61.19 USD By Investing.com - Investing.com Nigeria
Apogee Therapeutics’ Stock Surge: Is It Time To Jump In? - timothysykes.com
Apogee Therapeutics stock hits 52-week high at 61.19 USD - Investing.com India
Apogee Therapeutics Inc Stock (APGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):